Sexual and Urinary Changes During Menopause: Starting the Conversation

During and after menopause, oestrogen levels fall significantly. Oestrogen plays a central role in maintaining the tissues of the vagina, vulva, and lower urinary tract — keeping them elastic, well-lubricated, and resilient. As levels decline, these tissues can become thinner, drier, and less flexible, a process sometimes called genitourinary syndrome of menopause. This is not a disease but a physiological response to hormonal change.

The lower urinary tract — including the bladder and urethra — shares similar oestrogen-sensitive tissue, which is why urinary symptoms often appear alongside vaginal ones. The two are connected anatomically and hormonally, so it makes sense to think about them together rather than as separate problems.

It is important to distinguish this normal transition from conditions that need separate assessment. Persistent pain, bleeding after menopause, or urinary symptoms that are severe or worsening should be discussed with a clinician, because while they may well be related to menopause, other causes need to be considered in context.

Vaginal dryness is one of the most frequently reported menopausal symptoms, yet it is often underreported because people feel it is trivial or embarrassing. It is neither. Reduced lubrication can cause discomfort during everyday activities, not only during sex, and it can affect confidence and quality of life in ways that are entirely valid to raise with a healthcare professional.

The discomfort tends to be described as a persistent dryness, irritation, or a sensation of tightness. Unlike hot flushes, which often ease over time, vaginal dryness can persist or worsen without attention. This distinction matters when deciding whether to seek support — waiting for it to resolve on its own is not always the most useful approach.

Non-hormonal vaginal moisturisers and lubricants are one category of option that does not require a prescription and can be used independently. These address the immediate symptom rather than the underlying tissue change. Whether additional approaches are appropriate is a clinical conversation, not a decision to make in isolation from a healthcare professional who knows your full health picture.

Shifts in libido during menopause are common and can arise from several overlapping factors: hormonal changes, physical discomfort during sex, disrupted sleep, mood changes, and the psychological weight of navigating a significant life transition. Attributing a change in desire to a single cause is rarely accurate.

It is also worth separating a change in desire from distress about that change. Some people find their relationship with sex evolves during this period in ways that feel acceptable or even welcome. Others find the shift troubling, particularly if it affects a relationship or their sense of self. Both responses are legitimate, and neither requires a particular course of action unless the person themselves wants to explore options.

Physical discomfort during sex — particularly pain caused by vaginal dryness or reduced elasticity — can itself reduce desire over time, as the body learns to associate intimacy with discomfort. Addressing the physical symptom can sometimes shift the picture considerably. This is worth raising explicitly with a clinician rather than assuming reduced desire is purely psychological.

Urinary urgency — a sudden, strong need to urinate — and increased frequency are recognised menopausal symptoms linked to changes in the tissues lining the bladder and urethra. Some people also notice they are more prone to urinary tract infections during this period, which can be frustrating and disruptive.

These symptoms exist on a spectrum. Mild urgency that is manageable and not worsening is different from urgency that significantly limits daily activity or causes leakage. The NHS notes that urinary symptoms are among the changes associated with menopause, and they are worth mentioning to a clinician even if they feel minor, because they can be assessed and often improved.

Urinary symptoms should not be assumed to be menopausal without consideration of other possibilities. A urinary tract infection, for example, needs its own assessment and management. If symptoms are new, severe, include blood in the urine, or are accompanied by pain, these warrant prompt clinical attention rather than a wait-and-see approach.

The pelvic floor — the group of muscles supporting the bladder, bowel, and uterus — can be affected by the hormonal and tissue changes of menopause. Reduced tissue elasticity and changes in muscle tone can contribute to both urinary symptoms and discomfort during sex. These are not inevitable or permanent features of menopause, but they are common enough to be worth understanding.

Pelvic floor function exists on a continuum. Some people experience weakness, which can contribute to leakage. Others experience increased tension, which can contribute to pain. The appropriate approach differs depending on which pattern is present, which is why self-directed interventions based on general advice may not always be well-matched to an individual’s situation.

A referral to a pelvic health physiotherapist is one route that a GP can facilitate if symptoms suggest pelvic floor involvement. This is a form of assessment and guided support, not a treatment with guaranteed outcomes. Raising pelvic floor concerns as part of a broader menopause conversation is entirely appropriate and often welcomed by clinicians.

Many people delay raising sexual or urinary symptoms because they feel these topics are too personal, too minor, or unlikely to be taken seriously. In practice, clinicians who manage menopause expect these questions and are trained to address them. The barrier is usually in the room before the appointment, not in it.

Preparing a brief, honest account of what you are experiencing — when it started, how it affects daily life, and what you have already tried — makes the conversation more productive. You do not need clinical language. Describing symptoms in plain terms is entirely sufficient. If you find it difficult to raise the topic verbally, writing it down beforehand or handing a note to the clinician at the start of the appointment is a practical alternative.

NICE guidance on menopause supports the discussion of genitourinary symptoms as part of menopause care. Knowing that these symptoms are within the expected scope of a menopause consultation can make it easier to raise them without feeling you are overstepping.

A clinical assessment of sexual or urinary symptoms in the context of menopause is usually conversational and focused on understanding the pattern, severity, and impact of symptoms. It is not automatically invasive. A clinician may ask about the nature of the symptoms, their timing, any relevant medical history, and what effect they are having on daily life and relationships.

Depending on what emerges, they may suggest a physical examination, a urine test, or a referral. They may also discuss options ranging from non-hormonal approaches to hormonal ones, depending on your individual circumstances and preferences. This is a discussion, not a prescription — you are entitled to ask questions, take time to consider options, and return for a follow-up.

Screening and diagnosis are distinct. A conversation about symptoms is a starting point for assessment, not a conclusion. A clinician will decide whether the history is sufficient or whether examination or investigations are needed. A single appointment may begin an ongoing assessment rather than resolve every question.

Menopause-related sexual and urinary changes do not define a person’s wellbeing or the quality of their relationships and daily life. Many people find that once symptoms are acknowledged and addressed — even partially — their overall sense of ease improves considerably. Meaningful function and satisfaction are possible across a wide range of circumstances.

Some changes may persist to a degree even with support, and adapting to a new normal is a reasonable and valid response. This might involve adjusting expectations, communicating differently with a partner, or finding that some activities require more preparation than before. None of this represents failure or loss — it represents an honest engagement with a changing body.

If symptoms are affecting mental health, relationships, or daily function significantly, raising this explicitly with a clinician matters. Menopause care can involve psychological support as well as physical management, and the two are not mutually exclusive.

Changes in sleep, concentration, nutrition, movement, and recovery may be relevant to a broader SENSES health assessment. Bring your questions and any existing clinical information so that the review can consider your circumstances and current care.

These guides provide education about women’s health and menopause. They do not establish that specialist menopause consultations, hormone testing, or prescribing are included in a SENSES programme. Confirm the appropriate professionals and any external referrals through the individual suitability discussion.

• NICE guideline NG23: Menopause — identification and management
• NHS: Menopause and perimenopause symptoms